Locus 134: SLC7A9 (19q13.11)
| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs8101881 |
homocitrulline |
T/C |
3950 |
0.61 |
0.033 (0.004) |
1.43·10-16 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs8101881 |
| Chromosomal location | Chr19: 38,056,468 (19q13.11) |
| Gene (distance) | SLC7A9 (3,946) |
| Predicted causal gene | SLC7A9 |
| Gene/protein classification | - |
| Metabolite (Pathway) | homocitrulline (Urea cycle; arginine-, proline-, metabolism; Amino acid) |
| Biochemical locus-metabolite relationship | SLC7A9 associates with urine levels of lysine [21572414]. Mitochondria can convert lysine to homocitrulline through the action of a lysine transcarbamylase, although the enzyme responsible for this activity has not yet been identified [6409607] |
| eQTL associations | SLC7A9 (F), SLC7A9 (S) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information |
| Complex trait associations | Chronic kidney disease [20383146] |
| Known metabolite associations | Urinary metabolites [21572414] |
| Inborn error of metabolism | Cystinuria type B |
| Pharmacological information |
| ChEMBL ID | - |
| Drug information |
-
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

